1-[(2R)-N’-Boc-2-amino-2-cyclohexylacetyl]-N-(4’-cyanobenzyl)-2-L-azetidinecarboxamide-d11

1-[(2R)-N’-Boc-2-amino-2-cyclohexylacetyl]-N-(4’-cyanobenzyl)-2-L-azetidinecarboxamide-d11 is a deuterated form of a compound that is used in chemical research and drug development. This compound is a labeled form of 1-[(2R)-N’-Boc-2-amino-2-cyclohexylacetyl]-N-(4’-cyanobenzyl)-2-L-azetidinecarboxamide, which is a potent and selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). DPP-4 is an important therapeutic target for the treatment of type 2 diabetes, as it plays a key role in the regulation of blood glucose levels. The deuterated form of this compound is used in studies that require the use of isotopically labeled compounds to track metabolic pathways or to study the pharmacokinetics of the compound. The incorporation of deuterium into the compound can also alter its chemical properties, such as its solubility or stability, which can be useful in drug development. The chemical information of this compound includes its molecular formula, which is C32H44D11N5O4, and its molecular weight, which is 612.81 g/mol. It has a melting point of approximately 155-157°C and is soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol. The compound is stable under normal laboratory conditions and should be stored in a cool and dry place.